Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Infectious Disease · Eumycetoma

Understanding Your Mycetoma Diagnosis

At a Glance

Eumycetoma is a slow-growing fungal infection of the skin and deeper tissue, often affecting the foot after a thorn or splinter injury. Diagnosis usually requires specialist assessment, laboratory testing, and imaging to distinguish it from bacterial mycetoma and assess spread.

Receiving a diagnosis of eumycetoma (also called eumycotic mycetoma) can be overwhelming, especially because it is a condition many people—including some healthcare providers—have never heard of. It is important to know that you are not alone, and your experience of a slow, often confusing path to diagnosis is common for this condition [1][2].

What is Eumycetoma?

Eumycetoma is a chronic, localized infection caused by fungi [3]. It typically starts in the skin or the tissue just beneath the skin (subcutaneous tissue) and progresses very slowly over months or years [4].

While it can appear anywhere on the body, it most frequently affects the feet [4]. The hallmark of the infection is a “triad” of symptoms:

  • Localized Swelling: A firm, often painless lump under the skin [5].
  • Sinus Tracts: Small openings or “tunnels” that form from the deep infection to the surface of the skin [3].
  • Grains: Tiny, seed-like particles that are discharged through the sinus tracts. These grains are compact aggregates of fungal elements and host material [3].

It is vital to distinguish eumycetoma from actinomycetoma, which looks almost identical but is caused by bacteria rather than fungi [3][6]. Because the treatments for fungi and bacteria are completely different, your doctor must use laboratory tests to confirm which type you have [7].

The Mycetoma Belt

Eumycetoma is most common in a geographical region known as the mycetoma belt [8]. This “belt” spans tropical and subtropical areas between the latitudes of 15° South and 30° North [9]. It includes parts of:

  • Africa: Particularly Sudan, Senegal, and Somalia [10][11].
  • Asia: Including India and the Arabian Peninsula [8][12].
  • Latin America: Including Mexico and parts of South America [13].

The fungi that cause this infection live in the environment—specifically in the soil and on thorny plants like acacia trees [9][14]. Because of this, the people most often affected are those who work closely with the land, such as farmers, laborers, and herdsmen [8]. It is most frequently diagnosed in men between the ages of 20 and 50, though anyone exposed to the fungi can develop the condition [8].

How the Infection Starts

Eumycetoma does not spread from person to person. Instead, it begins through traumatic inoculation—this simply means the fungus is “pushed” into your body through a break in the skin [15][16].

Common ways this happens include:

  • Stepping on a thorn while walking barefoot [14].
  • A puncture wound from a splinter or sharp plant material [15].
  • Minor cuts or scratches sustained while handling soil or animal dung [14].

Once the fungus enters the tissue, it does not spread quickly like a typical “infection” (such as a skin abscess). Instead, it survives by forming hard grains, which are compact aggregates of fungal elements and host material [3]. It grows slowly and steadily, gradually involving nearby muscles and, if left untreated, it carries a serious risk of eventually reaching the bone [17][18].

Why Diagnosis is Often Delayed

It is very common for eumycetoma to go undiagnosed for a long time. There are several scientific and practical reasons for this delay:

  1. Painless Early Stage: In its early stages, the swelling is usually painless [5]. Many people wait to seek medical help because the lump doesn’t interfere with their daily work [19].
  2. Missing “Hallmarks”: The signature sinus tracts and grains often don’t appear until the infection has been present for a long time [1]. Without these, a doctor might mistake the lump for a simple cyst or a non-cancerous tumor [20].
  3. Low Awareness: Outside of highly endemic areas (like central Sudan), many doctors have never seen a case of mycetoma. It may be misdiagnosed as tuberculosis of the skin or a common bacterial infection [20][2].
  4. Complex Testing: Identifying the specific fungus (like Madurella mycetomatis, the most common cause) requires specialized laboratory equipment and expertise that may not be available in rural clinics [21][17].

If you have been struggling for months or years to find an answer, your experience is a known challenge of this disease. Confirming the diagnosis through biopsy (taking a small tissue sample), culture (growing the fungus in a lab), or imaging like MRI or ultrasound is the first step toward effective management [17][7].

What should I do next? This infection cannot be spread to others. Confirming it requires a specialist. Do not start antifungals on your own or delay clinical assessment while waiting for advanced testing.

Common questions in this guide

What is eumycetoma and what symptoms does it cause?
Eumycetoma is a chronic, localized fungal infection that usually begins in the skin or tissue beneath it, often in the foot. It commonly causes a firm swelling, sinus tracts or small openings, and grains that may drain through the skin; early swelling is often painless.
How is eumycetoma different from actinomycetoma?
Eumycetoma is caused by fungi, while actinomycetoma is caused by bacteria. They can look very similar, so laboratory testing is needed because the treatment approach differs.
How does someone get eumycetoma, and can it spread to other people?
The infection usually starts when soil- or plant-dwelling fungi enter through a thorn prick, splinter, or another break in the skin. Eumycetoma does not spread from person to person.
Which tests confirm an eumycetoma diagnosis?
A clinician may use a biopsy, culture, or PCR to identify the infection and determine whether it is fungal or bacterial. MRI or ultrasound can help assess how far it extends into nearby tissues.
Can an MRI or ultrasound show how deep eumycetoma is?
MRI or ultrasound may show the extent of the infection and can sometimes reveal a characteristic dot-in-circle sign. Imaging is interpreted together with the examination and laboratory results rather than used alone to identify the specific fungus.
Why is eumycetoma often diagnosed late?
The early lump is often painless, and the draining openings and grains may not appear until the infection has been present for a long time. Limited awareness and access to specialized fungal testing can also lead to mistaken diagnoses.
What should I do after eumycetoma is suspected or diagnosed?
Arrange assessment with a clinician or specialist who can confirm the diagnosis and evaluate whether the infection has reached deeper tissue. Do not start antifungal medicine on your own or delay clinical assessment while waiting for advanced testing.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on eumycotic mycetoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do I have eumycetoma (fungal) or actinomycetoma (bacterial), and which tests were used to confirm this?
  2. 2.What specific fungal species was identified in my culture or PCR test?
  3. 3.How deep does the infection go—has it reached my muscles, tendons, or bones?
  4. 4.Can we use an MRI or ultrasound to look for the 'dot-in-circle' sign to confirm the extent of the disease?
  5. 5.Is the laboratory that processed my biopsy experienced in identifying tropical fungal infections?
  6. 6.Based on the size and location of my lesion, what is the long-term plan for managing this?

References

References (21)
  1. 1

    Dot-in-Circle Sign - A Diagnostic MRI Sign for "Madura Foot".

    Javed F, Nazir R, Sharma M, et al.

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2017; (27(3)):S8-S10 doi:236.

    PMID: 28302229
  2. 2

    Madurella mycetomatis infection of the foot: a case report of a neglected tropical disease in a non-endemic region.

    Karrakchou B, Boubnane I, Senouci K, Hassam B

    BMC dermatology 2020; (20(1)):1 doi:10.1186/s12895-019-0097-1.

    PMID: 31918687
  3. 3

    Mycetoma: reviewing a neglected disease.

    Verma P, Jha A

    Clinical and experimental dermatology 2019; (44(2)):123-129 doi:10.1111/ced.13642.

    PMID: 29808607
  4. 4

    Unusual Presentation of Eumycetoma (Madura Foot): A Case Report.

    Nishat SMH, Ibrahim D, Oommen S, Potula PC

    Cureus 2026; (18(3)):e104719 doi:10.7759/cureus.104719.

    PMID: 41939684
  5. 5

    Long term follow-up of Maduromycosis treatment: A case review.

    Saleh R, Nong I, Guatama A, et al.

    International journal of surgery case reports 2021; (82()):105956 doi:10.1016/j.ijscr.2021.105956.

    PMID: 33984729
  6. 6

    Clinical Features of Mycetoma and the Appropriate Treatment Options.

    Agarwal P, Jagati A, Rathod SP, et al.

    Research and reports in tropical medicine 2021; (12()):173-179 doi:10.2147/RRTM.S282266.

    PMID: 34267575
  7. 7

    Mycetoma imaging: the best practice.

    Bahar ME, Bakheet OELH, Fahal AH

    Transactions of the Royal Society of Tropical Medicine and Hygiene 2021; (115(4)):387-396 doi:10.1093/trstmh/traa178.

    PMID: 33537774
  8. 8

    Global sociodemographic, clinical, and epidemiological profiling of patients with mycetoma: A systematic review.

    Salah ME, Fearon Scales ML, Habib K, et al.

    PLoS neglected tropical diseases 2025; (19(8)):e0013217 doi:10.1371/journal.pntd.0013217.

    PMID: 40811735
  9. 9

    Modelling the spatial distribution of mycetoma in Sudan.

    Hassan R, Simpson H, Cano J, et al.

    Transactions of the Royal Society of Tropical Medicine and Hygiene 2021; (115(10)):1144-1152 doi:10.1093/trstmh/trab076.

    PMID: 34037803
  10. 10

    A conserved grain-associated immunosuppressive niche in Sudanese patients with mycetoma.

    Osman M, Ashwin H, Calder G, et al.

    PLoS neglected tropical diseases 2026; (20(8)):e0014230 doi:10.1371/journal.pntd.0014230.

    PMID: 42607090
  11. 11

    Direct 16S/ITS rRNA Gene PCR Followed by Sanger Sequencing for Detection of Mycetoma Causative Agents in Dakar, Senegal: A Pilot Study Among Patients with Mycetoma Attending Aristide Le Dantec University Hospital.

    Diongue K, Dione JN, Diop A, et al.

    Mycopathologia 2024; (189(5)):80 doi:10.1007/s11046-024-00891-w.

    PMID: 39249620
  12. 12

    Mycetoma in north-western Yemen: Clinico-epidemiological and histopathological study.

    Khatri ML, Al Kubati SAS, Gaffer IA, Majeed SMA

    Indian journal of dermatology, venereology and leprology 2022; (88(5)):615-622.

    PMID: 35389029
  13. 13

    The global distribution of actinomycetoma and eumycetoma.

    Emery D, Denning DW

    PLoS neglected tropical diseases 2020; (14(9)):e0008397 doi:10.1371/journal.pntd.0008397.

    PMID: 32970667
  14. 14

    Metagenomic detection of eumycetoma causative agents   from households of patients residing in two Sudanese endemic villages in White Nile State.

    Santona A, Mhmoud NA, Siddig EE, et al.

    PLoS neglected tropical diseases 2022; (16(8)):e0010385 doi:10.1371/journal.pntd.0010385.

    PMID: 36040926
  15. 15

    Mycetoma: a unique neglected tropical disease.

    Zijlstra EE, van de Sande WWJ, Welsh O, et al.

    The Lancet. Infectious diseases 2016; (16(1)):100-112 doi:10.1016/S1473-3099(15)00359-X.

    PMID: 26738840
  16. 16

    Rapid and Robust Identification of the Agents of Black-Grain Mycetoma by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.

    Fraser M, Borman AM, Johnson EM

    Journal of clinical microbiology 2017; (55(8)):2521-2528 doi:10.1128/JCM.00417-17.

    PMID: 28592546
  17. 17

    Comparing the performance of the common used eumycetoma diagnostic tests.

    Siddig EE, Nyuykonge B, Mhmoud NA, et al.

    Mycoses 2023; (66(5)):420-429 doi:10.1111/myc.13561.

    PMID: 36583225
  18. 18

    Successful Treatment of Recalcitrant Actinomycetoma of Gluteal Area with Combined Medical Treatment and Surgical Excision with Graft Reconstruction.

    Al-Kathiri L, Al-Najjar T, Al-Asmaili A

    Oman medical journal 2020; (35(2)):e111 doi:10.5001/omj.2020.29.

    PMID: 32308989
  19. 19

    Mycetoma: a clinical dilemma in resource limited settings.

    Emmanuel P, Dumre SP, John S, et al.

    Annals of clinical microbiology and antimicrobials 2018; (17(1)):35 doi:10.1186/s12941-018-0287-4.

    PMID: 30097030
  20. 20

    Madura foot and a continued diagnostic enigma: Dot-in-circle sign on magnetic resonance imaging and ultrasound.

    Hailemariam T, Tamiru R, Manyazewal T, et al.

    IDCases 2023; (33()):e01857 doi:10.1016/j.idcr.2023.e01857.

    PMID: 37546173
  21. 21

    Mycetoma in West Africa.

    Oladele RO, Ly F, Sow D, et al.

    Transactions of the Royal Society of Tropical Medicine and Hygiene 2021; (115(4)):328-336 doi:10.1093/trstmh/trab032.

    PMID: 33728466

This page is for informational purposes only and does not constitute medical advice. A clinician experienced with eumycetoma should interpret your tests and guide your next steps.